S

Surgical Science Sweden AB
STO:SUS

Watchlist Manager
Surgical Science Sweden AB
STO:SUS
Watchlist
Price: 159.1 SEK -1.49% Market Closed
Market Cap: 8.1B SEK
Have any thoughts about
Surgical Science Sweden AB?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

52.2
Current
45.8
Median
12.7
Industry
Higher than median
Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
52.2
=
Enterprise Value
7.5B SEK
/
EBITDA
142.8m SEK
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
32.2
2-Years Forward
EV/EBITDA
20
3-Years Forward
EV/EBITDA
14.6

See Also

Discover More